IMPLANET (Paris: IMPL) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces that it has obtained regulatory clearance from the FDA (Food and Drug Administration) to market its 3.5 mm, 4.0 mm, 4.5